Acarbose Export Market Intelligence: India's 61 Suppliers Shipping to 37 Countries — TransData Nexus 2026

Q: Who are the top acarbose exporters from India?

The top acarbose exporters from India are: 1. STRIDES PHARMA SCIENCE LIMITED — $4.4M (65.5% market share); 2. EMCURE PHARMACEUTICALS LIMITED — $766.6K (11.4% market share); 3. MICRO LABS LIMITED — $411.5K (6.1% market share); 4. AUROBINDO PHARMA LTD — $381.6K (5.7% market share); 5. EMCURE PHARMACEUTICALS LTD — $219.7K (3.3% market share). Together they account for 91.9% of India's total acarbose export value.

Q: What is the total export value of acarbose from India?

The total export value of acarbose from India is $6.8M USD, recorded across 914 shipment transactions from 61 active exporters to 37 destination countries. The average shipment value is $7.4K.

Q: Which countries import acarbose from India?

India exports acarbose to 37 countries worldwide. The top importing countries are: UNITED STATES (65.5% share, $4.4M), CANADA (14.6% share, $986.3K), SRI LANKA (6.7% share, $450.3K), FRANCE (6.5% share, $437.3K), JAMAICA (3.7% share, $250.4K). These five markets account for 97.0% of total export value.

Q: What is the HS code for acarbose exports from India?

The primary HS code for acarbose exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of acarbose exports from India?

The average unit price for acarbose exports from India is $6.95 USD per unit, with prices ranging from $0.00 to $1552.18 depending on formulation, packaging, and order volume. The total market is valued at $6.8M across 914 shipments.

Q: Which ports handle acarbose exports from India?

The primary ports for acarbose exports from India are DELHI AIR CARGO ACC (INDEL4) (29.1% of shipments), DELHI AIR (19.3% of shipments), SAHAR AIR (12.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.5% of shipments), Delhi Air (4.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of acarbose?

India is one of the world's leading exporters of acarbose due to its large base of 61 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports acarbose to 37 countries, demonstrating 19% global market coverage.

Q: What certifications do Indian acarbose exporters need?

Indian acarbose exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import acarbose from India?

There are 82 registered buyers importing acarbose from India, spread across 37 countries. The repeat buyer rate is 73.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top acarbose supplier from India?

STRIDES PHARMA SCIENCE LIMITED is the leading acarbose exporter from India with a market share of 65.5% and total export value of $4.4M across 51 shipments. The top 5 suppliers together control 91.9% of total export value.

Suresh Sormare

Acarbose

India Pharmaceutical Trade Intelligence

$6.8M61 Suppliers37 CountriesHS 30049099

ExportsIndia → UNITED STATES65.5%India → CANADA14.6%

ImportsROMANIA → India$991 GERMANY → India$99

#1 Supplier: STRIDES PHARMA #1 Buyer: STRIDES PHARMA

Acarbose Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Acarbose to the World

Between 2022 and 2026, India exported $6.8M worth of acarbose across 914 verified shipments to 37 countries — covering 19% of world markets in the Advanced Diabetes Medications segment. The largest destination is UNITED STATES (65.5%). STRIDES PHARMA SCIENCE LIMITED leads with a 65.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Acarbose export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Acarbose export data snapshot — $6.8M · 61 exporters · 37 countriesTransData Nexus · Indian Customs Data

Top Acarbose Exporters from India

61 active exporters · Ranked by export value

View all 61 →

Top Acarbose Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	STRIDES PHARMA SCIENCE LIMITED	$4.4M	51	1	65.5%
2	EMCURE PHARMACEUTICALS LIMITED

Top Countries Importing Acarbose from India

37 destination markets · Ranked by import value

All 37 countries →

Top Countries Importing Acarbose from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$4.4M	65.5%
2	CANADA	$986.3K	14.6%
3	SRI LANKA	$450.3K	6.7%
4	FRANCE	$437.3K	6.5%
5	JAMAICA	$250.4K	3.7%
6	MYANMAR	$82.0K	1.2%
7	MAURITIUS	$38.7K	0.6%
8	MALTA	$26.1K	0.4%
9	SWITZERLAND	$15.8K	0.2%
10	THAILAND	$13.9K	0.2%

UNITED STATES is India's largest acarbose export destination, absorbing 65.5% of total exports worth $4.4M. The top 5 importing countries — UNITED STATES, CANADA, SRI LANKA, FRANCE, JAMAICA — together account for 97.0% of India's total acarbose export value. The remaining 32 destination countries collectively receive the other 3.0%, indicating a focused distribution strategy targeting key markets.

Who Supplies Acarbose to India?

4 origin countries · Total import value: $1.2K

India imports acarbose from 4 countries with a combined import value of $1.2K. The largest supplier is ROMANIA ($991, 1 shipments), followed by GERMANY and MALTA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Acarbose to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ROMANIA	$991	1	85.5%
2	GERMANY	$99	1	8.5%
3	MALTA	$45	4	3.9%
4	SINGAPORE	$24	2	2.0%

ROMANIA is the largest supplier of acarbose to India, accounting for 85.5% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Acarbose — Export Intelligence Video

Visual overview of India's acarbose import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's acarbose pharmaceutical import and export market — $6.8M in total trade, 61 verified manufacturers, and 37 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Acarbose

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Acarbose, an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus, has been approved in the United States under the brand name Precose. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for generic versions of acarbose tablets, indicating a competitive generic market. Notably, Roxane Laboratories, Inc. received approval for its ANDA 78-470 for Acarbose Tablets (25 mg, 50 mg, and 100 mg) on August 30, 2006.

The United States is the primary destination for Indian exports of acarbose, accounting for 65.5% of the total export value. This substantial market share underscores the importance of compliance with FDA regulations for Indian exporters. The FDA's regulatory pathway for generic drugs involves demonstrating bioequivalence to the reference listed drug, ensuring consistent quality, efficacy, and safety. As of March 2026, there are no active FDA import alerts specifically targeting acarbose, suggesting that current imports meet the agency's standards.

2EU & UK Regulatory Framework

In the European Union, acarbose is authorized for use in the treatment of type 2 diabetes mellitus. The European Medicines Agency (EMA) oversees the approval and monitoring of medicinal products within the EU. Acarbose has been subject to periodic safety updates, with the most recent procedure (PSUSA/00000017/201803) concluded on November 29, 2018. (ema.europa.eu)

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the authorization of medicinal products. Post-Brexit, the UK has established its own regulatory framework, though it continues to align closely with EU standards. Manufacturers exporting acarbose to the UK must ensure compliance with MHRA requirements, including adherence to Good Manufacturing Practice (GMP) standards.

3WHO Essential Medicines & Global Standards

Acarbose is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The WHO Model List serves as a guide for the development of national and institutional essential medicine lists. Additionally, acarbose is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications across different regions.

4India Regulatory Classification

In India, acarbose is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines. As of March 2026, acarbose is not listed under the DPCO's price control list, allowing manufacturers to set prices based on market dynamics. For export purposes, Indian pharmaceutical companies must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The primary patent for acarbose, U.S. Patent No. 4,904,769, expired on September 6, 2009. This expiration has led to the entry of multiple generic versions into the market, increasing competition and accessibility. The absence of active patents or exclusivity periods as of March 2026 indicates a favorable environment for generic manufacturers and exporters.

6Recent Industry Developments

In July 2025, the European Medicines Agency (EMA) adopted a positive opinion recommending an extension to the existing indication for Baqsimi (glucagon) to include treatment of severe hypoglycemia in children with diabetes mellitus from 1 year of age. (ema.europa.eu) While not directly related to acarbose, this development reflects the ongoing advancements in diabetes management therapies within the EU.

In December 2025, the UK's Food Standards Agency (FSA) implemented the Genetic Technology (Precision Breeding) Regulations 2025, allowing businesses to apply for Precision Bred Organism (PBO) food and feed marketing authorizations. (food.gov.uk) Although this regulation primarily pertains to genetically modified organisms, it signifies the UK's commitment to modernizing its regulatory framework for food and feed products, which may have indirect implications for pharmaceutical exports.

These developments highlight the dynamic nature of the regulatory landscape in key export markets, emphasizing the need for continuous monitoring and compliance by Indian exporters of acarbose.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Acarbose

Retail & reference prices across 9 markets vs. India FOB export price of $6.95/unit

Global Price Benchmark for Acarbose across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.41	USD	According to the FDA Orange Book, Acarbose is approved for use in the United States.
United Kingdom	$0.39	GBP	Acarbose is listed in the NHS Drug Tariff, indicating its availability and pricing within the National Health Service.
Germany	$0.38	EUR	Acarbose is regulated by the Federal Institute for Drugs and Medical Devices (BfArM) in Germany.
Australia	$0.33	AUD

Supply Chain Risk Assessment — Acarbose

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Acarbose, an alpha-glucosidase inhibitor used in managing type 2 diabetes, is primarily produced in India and China. While India has a robust pharmaceutical manufacturing sector, it heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 68% of India's API imports, including those for antidiabetic drugs like acarbose, originate from China. This dependency exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or environmental regulations affecting Chinese production facilities.

In recent years, China's stringent environmental policies have led to the shutdown of numerous chemical manufacturing plants, causing significant supply chain disruptions and escalating costs for APIs and KSMs. Such events underscore the vulnerability of India's pharmaceutical industry due to its reliance on Chinese raw materials. The COVID-19 pandemic further highlighted these risks, as lockdowns and export restrictions in China led to shortages and price volatility in essential drugs.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters account for 91.9% of acarbose exports, with STRIDES PHARMA SCIENCE LIMITED alone contributing 65.5% ($4.4 million USD). This high supplier concentration poses a significant single-source risk; any operational or regulatory issues affecting these key players could disrupt the global supply of acarbose.

Access Complete Acarbose Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 914 transactions across 37 markets.

Request Demo View Pricing

Frequently Asked Questions — Acarbose Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top acarbose exporters from India?

The leading acarbose exporters from India are STRIDES PHARMA SCIENCE LIMITED, EMCURE PHARMACEUTICALS LIMITED, MICRO LABS LIMITED, and 9 others. STRIDES PHARMA SCIENCE LIMITED leads with 65.5% market share ($4.4M). The top 5 suppliers together control 91.9% of total export value.

What is the total export value of acarbose from India?

The total export value of acarbose from India is $6.8M, recorded across 914 shipments from 61 active exporters to 37 countries. The average shipment value is $7.4K.

Which countries import acarbose from India?

India exports acarbose to 37 countries. The top importing countries are UNITED STATES (65.5%), CANADA (14.6%), SRI LANKA (6.7%), FRANCE (6.5%), JAMAICA (3.7%), which together account for 97.0% of total export value.

What is the HS code for acarbose exports from India?

The primary HS code for acarbose exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Acarbose

Acarbose

Top Acarbose Exporters from India

Top Countries Importing Acarbose from India

Who Supplies Acarbose to India?

Quick Facts

Related Advanced Diabetes Medications

Related Analysis

Need Details?

Acarbose — Export Intelligence Video

Regulatory Landscape — Acarbose

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Acarbose

Supply Chain Risk Assessment — Acarbose

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Acarbose Trade Intelligence

Frequently Asked Questions — Acarbose Exports from India

Who are the top acarbose exporters from India?

What is the total export value of acarbose from India?

Which countries import acarbose from India?

What is the HS code for acarbose exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of acarbose exports from India?

Which ports handle acarbose exports from India?

Why is India a leading exporter of acarbose?

What certifications do Indian acarbose exporters need?

How many buyers import acarbose from India?

What is the market share of the top acarbose exporter from India?

Analysis Methodology